in this issue
Regions :: Western Europe
Bayer reports 42% rise in third-quarter net income on flat sales
9:13 AM MDT | October 31, 2013 | Michael Ravenscroft
Bayer has reported "continued positive business momentum" in third-quarter 2013 with "substantial contributions from HealthCare and CropScience." "We are maintaining our guidance for the group for 2013, although it is increasingly ambitious," says Bayer chairman Marijn Dekkers. Group net income rose 42%, to €733 million ($1.01 billion), on flat sales, at €9.64 billion. Ebit climbed 47.5%, to €1.22 billion, and Ebitda before special items increased 7.7%, to €1.98 billion. Core earnings per share rose 8.5%, to...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee